ANTAGONIST AND AGONIST BINDING TO STRONG BINDING SITE OF CHEMOKINE RECEPTOR

An antagonist or an agonist which binds to a strong binding site of CCR5; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the same; a method for screening a compound which binds to a strong binding site of CCR5...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KENJI SAGAWA, KAZUHIKO TAKEDA, HIDEAKI TADA, NORIKI WATANABE, DAIKICHI FUKUSHIMA, SHIRO SHIBAYAMA
Format:	Patent
Sprache:	eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	KENJI SAGAWA KAZUHIKO TAKEDA HIDEAKI TADA NORIKI WATANABE DAIKICHI FUKUSHIMA SHIRO SHIBAYAMA
description	An antagonist or an agonist which binds to a strong binding site of CCR5; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the same; a method for screening a compound which binds to a strong binding site of CCR5; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the antagonist or the agonist selected by the screening method; an antagonist or an agonist which binds to a strong binding site of a chemokine receptor; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the same; a method for screening a compound which binds to a strong binding site of a chemokine receptor; and a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the antagonist or the agonist selected by the screening method. The antagonist or the agonist of the present invention is useful as a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2003289329A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2003289329A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2003289329A13</originalsourceid><addsrcrecordid>eNrjZPB29AtxdPf38wwOUXD0c1GAsZ08_Vw8_dwVQvwVgkOC_IEsmEiwZ4irgr-bgrOHq6-_t6efq0KQq7NrQIh_EA8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstiXcMNTIwMDaysDQ2snQ0NCZOFQAwWy5l</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTAGONIST AND AGONIST BINDING TO STRONG BINDING SITE OF CHEMOKINE RECEPTOR</title><source>esp@cenet</source><creator>KENJI SAGAWA ; KAZUHIKO TAKEDA ; HIDEAKI TADA ; NORIKI WATANABE ; DAIKICHI FUKUSHIMA ; SHIRO SHIBAYAMA</creator><creatorcontrib>KENJI SAGAWA ; KAZUHIKO TAKEDA ; HIDEAKI TADA ; NORIKI WATANABE ; DAIKICHI FUKUSHIMA ; SHIRO SHIBAYAMA</creatorcontrib><description>An antagonist or an agonist which binds to a strong binding site of CCR5; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the same; a method for screening a compound which binds to a strong binding site of CCR5; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the antagonist or the agonist selected by the screening method; an antagonist or an agonist which binds to a strong binding site of a chemokine receptor; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the same; a method for screening a compound which binds to a strong binding site of a chemokine receptor; and a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the antagonist or the agonist selected by the screening method. The antagonist or the agonist of the present invention is useful as a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer.</description><edition>7</edition><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040709&DB=EPODOC&CC=AU&NR=2003289329A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040709&DB=EPODOC&CC=AU&NR=2003289329A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KENJI SAGAWA</creatorcontrib><creatorcontrib>KAZUHIKO TAKEDA</creatorcontrib><creatorcontrib>HIDEAKI TADA</creatorcontrib><creatorcontrib>NORIKI WATANABE</creatorcontrib><creatorcontrib>DAIKICHI FUKUSHIMA</creatorcontrib><creatorcontrib>SHIRO SHIBAYAMA</creatorcontrib><title>ANTAGONIST AND AGONIST BINDING TO STRONG BINDING SITE OF CHEMOKINE RECEPTOR</title><description>An antagonist or an agonist which binds to a strong binding site of CCR5; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the same; a method for screening a compound which binds to a strong binding site of CCR5; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the antagonist or the agonist selected by the screening method; an antagonist or an agonist which binds to a strong binding site of a chemokine receptor; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the same; a method for screening a compound which binds to a strong binding site of a chemokine receptor; and a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the antagonist or the agonist selected by the screening method. The antagonist or the agonist of the present invention is useful as a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPB29AtxdPf38wwOUXD0c1GAsZ08_Vw8_dwVQvwVgkOC_IEsmEiwZ4irgr-bgrOHq6-_t6efq0KQq7NrQIh_EA8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstiXcMNTIwMDaysDQ2snQ0NCZOFQAwWy5l</recordid><startdate>20040709</startdate><enddate>20040709</enddate><creator>KENJI SAGAWA</creator><creator>KAZUHIKO TAKEDA</creator><creator>HIDEAKI TADA</creator><creator>NORIKI WATANABE</creator><creator>DAIKICHI FUKUSHIMA</creator><creator>SHIRO SHIBAYAMA</creator><scope>EVB</scope></search><sort><creationdate>20040709</creationdate><title>ANTAGONIST AND AGONIST BINDING TO STRONG BINDING SITE OF CHEMOKINE RECEPTOR</title><author>KENJI SAGAWA ; KAZUHIKO TAKEDA ; HIDEAKI TADA ; NORIKI WATANABE ; DAIKICHI FUKUSHIMA ; SHIRO SHIBAYAMA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2003289329A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KENJI SAGAWA</creatorcontrib><creatorcontrib>KAZUHIKO TAKEDA</creatorcontrib><creatorcontrib>HIDEAKI TADA</creatorcontrib><creatorcontrib>NORIKI WATANABE</creatorcontrib><creatorcontrib>DAIKICHI FUKUSHIMA</creatorcontrib><creatorcontrib>SHIRO SHIBAYAMA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KENJI SAGAWA</au><au>KAZUHIKO TAKEDA</au><au>HIDEAKI TADA</au><au>NORIKI WATANABE</au><au>DAIKICHI FUKUSHIMA</au><au>SHIRO SHIBAYAMA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTAGONIST AND AGONIST BINDING TO STRONG BINDING SITE OF CHEMOKINE RECEPTOR</title><date>2004-07-09</date><risdate>2004</risdate><abstract>An antagonist or an agonist which binds to a strong binding site of CCR5; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the same; a method for screening a compound which binds to a strong binding site of CCR5; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the antagonist or the agonist selected by the screening method; an antagonist or an agonist which binds to a strong binding site of a chemokine receptor; a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the same; a method for screening a compound which binds to a strong binding site of a chemokine receptor; and a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer which comprises the antagonist or the agonist selected by the screening method. The antagonist or the agonist of the present invention is useful as a preventive and/or therapeutic agent for an allergic disease, an inflammatory disease, an immune disease and/or a cancer.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_AU2003289329A1
source	esp@cenet
subjects	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	ANTAGONIST AND AGONIST BINDING TO STRONG BINDING SITE OF CHEMOKINE RECEPTOR
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A22%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KENJI%20SAGAWA&rft.date=2004-07-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2003289329A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true